MICO BIOMED CO., LTD. Financials MiCo BioMed Co., Ltd.
Equities
A214610
KR7214610008
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,420 KRW | 0.00% |
|
-4.89% | -23.33% |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Capitalization 1 | 82,235 | 204,207 | 166,501 | 87,860 | 80,681 |
| Enterprise Value (EV) 1 | 91,484 | 186,810 | 151,796 | 97,147 | 71,704 |
| P/E ratio | -5.46 x | -28.4 x | -15.7 x | -2.26 x | -1.78 x |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | 20.1 x | 4.47 x | 5.49 x | 5.45 x | 15 x |
| EV / Revenue | 22.3 x | 4.09 x | 5.01 x | 6.03 x | 13.4 x |
| EV / EBITDA | -9.12 x | 35.6 x | -18 x | -4.21 x | -4.06 x |
| EV / FCF | - | -7,228,557 x | -16,703,865 x | 78,957,737 x | -4,372,895 x |
| FCF Yield | - | -0% | -0% | 0% | -0% |
| Price to Book | 78.3 x | 3.65 x | 3.19 x | 4.97 x | 2.18 x |
| Nbr of stocks (in thousands) | 14,641 | 21,782 | 21,956 | 21,965 | 43,564 |
| Reference price 2 | 5,617 | 9,375 | 7,583 | 4,000 | 1,852 |
| Announcement Date | 3/19/21 | 3/19/21 | 3/21/22 | 3/22/23 | 3/20/24 |
1KRW in Million2KRW
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Net sales 1 | 4,098 | 45,672 | 30,302 | 16,111 | 5,367 |
| EBITDA 1 | -10,036 | 5,242 | -8,419 | -23,075 | -17,673 |
| EBIT 1 | -11,747 | 3,466 | -10,859 | -25,922 | -19,983 |
| Operating Margin | -286.65% | 7.59% | -35.83% | -160.89% | -372.3% |
| Earnings before Tax (EBT) 1 | -14,655 | -5,789 | -10,598 | -38,932 | -25,808 |
| Net income 1 | -14,632 | -5,776 | -10,575 | -38,893 | -25,774 |
| Net margin | -357.04% | -12.65% | -34.9% | -241.4% | -480.2% |
| EPS 2 | -1,028 | -330.0 | -482.5 | -1,772 | -1,042 |
| Free Cash Flow | - | -25,843 | -9,088 | 1,230 | -16,397 |
| FCF margin | - | -56.58% | -29.99% | 7.64% | -305.5% |
| FCF Conversion (EBITDA) | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 3/19/21 | 3/19/21 | 3/21/22 | 3/22/23 | 3/20/24 |
1KRW in Million2KRW
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Net Debt 1 | 9,249 | - | - | 9,287 | - |
| Net Cash position 1 | - | 17,397 | 14,704 | - | 8,977 |
| Leverage (Debt/EBITDA) | -0.9216 x | - | - | -0.4025 x | - |
| Free Cash Flow | - | -25,843 | -9,088 | 1,230 | -16,397 |
| ROE (net income / shareholders' equity) | - | -20.3% | -19.6% | -111% | -95.6% |
| ROA (Net income/ Total Assets) | - | 4.51% | -8.5% | -22.2% | -21% |
| Assets 1 | - | -127,977 | 124,378 | 175,471 | 122,615 |
| Book Value Per Share 2 | 71.70 | 2,570 | 2,381 | 806.0 | 849.0 |
| Cash Flow per Share 2 | 675.0 | 958.0 | 1,085 | 259.0 | 215.0 |
| Capex 1 | 1,338 | 5,761 | 2,841 | 1,625 | 385 |
| Capex / Sales | 32.66% | 12.61% | 9.38% | 10.08% | 7.18% |
| Announcement Date | 3/19/21 | 3/19/21 | 3/21/22 | 3/22/23 | 3/20/24 |
1KRW in Million2KRW
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -23.33% | 45.33M | |
| -12.42% | 19.25B | |
| -40.05% | 2.96B | |
| +23.79% | 1.96B | |
| +1.29% | 1.69B | |
| +28.05% | 1.27B | |
| -14.61% | 982M | |
| -20.31% | 913M | |
| +4.64% | 801M | |
| -24.78% | 630M |
- Stock Market
- Equities
- A214610 Stock
- Financials MiCo BioMed Co., Ltd.